ReWalk Robotics, Inc.
ReWalk Robotics Ltd. Announces Closing of Initial Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares

DGAP-News: ReWalk Robotics, Inc.

17.09.2014 / 19:43

---------------------------------------------------------------------

YOKNEAM ILIT, Israel and MARLBOROUGH, Mass., 2014-09-17 19:43 CEST (GLOBE
NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq:RWLK), an innovative medical device
company that designs, develops and markets wearable robotic exoskeletons for
individuals with spinal cord injury, today announced the closing of its initial
public offering of 3,450,000 ordinary shares at $12.00 per share, which
includes 450,000 ordinary shares purchased pursuant to the full exercise of the
underwriters' option to purchase additional shares. All shares were issued and
sold by ReWalk. 

Barclays Capital Inc. and Jefferies LLC are the joint book-running managers for
the offering. Canaccord Genuity Inc. is the co-manager for the offering. 

A copy of the final prospectus related to the offering may be obtained when
available from: Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155
Long Island Ave, Edgewood, NY 11717, 888-603-5847, email:
Barclaysprospectus@broadridge.com or Jefferies LLC, 520 Madison Ave, 2nd Floor,
New York, NY 10022, 877-547-6340, email: Prospectus_Department@Jefferies.com. 

A registration statement relating to these securities has been filed and
declared effective by the U.S. Securities and Exchange Commission. This press
release shall not constitute an offer to sell or the solicitation of an offer
to buy any of the offered securities, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under the
securities laws of any such state or jurisdiction. 

About ReWalk Robotics Ltd.

ReWalk Robotics Ltd. (formerly Argo Medical Technologies Ltd.) designs,
develops and markets wearable robotic exoskeletons for individuals with spinal
cord injury. ReWalk's mission is to fundamentally change the health and life
experiences of individuals with spinal cord injury. Founded in 2001, ReWalk has
headquarters in the US, Israel and Germany. 


         CONTACT: Lisa Wilson
         In-Site Communications, Inc.
         Investor Relations
         T: (212) 452-2793
         E: lwilson@insitecony.com
News Source: NASDAQ OMX



---------------------------------------------------------------------

17.09.2014 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English                
Company:     ReWalk Robotics, Inc.  
 
 
             Israel                 
ISIN:        IL0011331076           
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
287538 17.09.2014